🇺🇸 FDA
Patent

US 9340792

Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses

granted A61KA61K2035/115A61K35/744

Quick answer

US patent 9340792 (Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses) held by Northwestern University expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2035/115, A61K35/744, A61K35/747, A61P